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Heart failure (HF) is a complex clinical syndrome resulting
from impaired diastolic and/or systolic function and clinically
manifested by numerous, rather unspecific symptoms such as
dyspnoea (at rest or exertion), orthopnoea, wheezing, chronic
fatigue and lower extremity oedema. The prevalence of HF
increases steeply with age, causing high mortality and morbid-
ity, substantial loss in quality of life, and high health care costs
[1]. For the diagnosis of HF, guidelines require, in addition to
symptoms, objective evidence of cardiac dysfunction that is
most commonly assessed by echocardiography. While many
conditions may cause HF, the most common aetiologies are
coronary artery disease (CAD) and hypertension.
Early diagnosis and adequate treatment are necessary to
improve symptoms and prognosis. General practitioners
(GPs) and nurse practitioners (NPs) play a key role in identi-
fying HF, but diagnosing HF in primary care remains chal-
lenging because symptoms are often unspecific, subtle or even
absent [2]. Advanced diagnostics are often not easily avail-
able, but diagnostic uncertainty may lead to inappropriate
treatment of wrongly diagnosed HF or delaying therapy when
the diagnosis is missed.
Echocardiography is the reference investigation for left
ventricular dysfunction and plays an important role to diag-
nose both diastolic and systolic dysfunction of the left ventri-
cle (class I, level C) [3]. There is an increase in the number of
open access echocardiography services to primary care for early
diagnosis and appropriate treatment of cardiac dysfunction and
HF. However, due to limited resources, adequate screening by
GPs or NPs remains imperative for cost-effective use of limited
resources. The question, therefore, arises which patients should
be investigated by echocardiography to provide best care. The
equivocal recommendation by themost recent guidelines on the
management of arterial hypertension by the ESC underscores
the difficulty of this question [4].
In this issue of the Netherlands Heart Journal, Ringoir et al.
report on the prevalence of symptoms related to HF in 591
elderly primary care patients with hypertension and the diag-
nostic value of these symptoms to predict cardiac dysfunction,
defined as an abnormal echocardiogram [5]. The investigators
included both systolic (LVEF < 55 %) and diastolic dysfunc-
tion parameters (left atrial volume index > 29 ml/m2, E/a ratio
< 1 and DT > 200 ms in presence of left ventricular hypertro-
phy), as well as valvular abnormalities, wall motion abnor-
malities, and right ventricular hypertrophy (≥ 6 mm) in their
definition of an abnormal echocardiogram, which was found
in 30 % of patients. Symptoms (i.e. restless sleep, cold
extremities, fatigue, shortness of breath, and ankle oedema)
were present in 13–25 % of the study population. Although
these symptoms were not sensitive (20–32 %), they were
rather specific for an abnormal echocardiogram (71–90 %).
Of these, the most specific symptom (i.e. ankle oedema) was,
however, also the least sensitive one. Still, it was the only one
adding to the risk of cardiac dysfunction independently to
already known clinical risk factors. The authors concluded
that elderly hypertensive primary care patients presenting with
ankle oedema might be appropriately referred for echocardio-
graphic screening. The question is if this statement is correct
and how it should be put into clinical perspective.
The investigators are to be complimented with their study,
because it addresses an important topic with many unresolved
issues, especially in primary care patients. Their results add
another missing piece to the diagnostic strategy puzzle in
primary care patients with suspected HF. However, the conclu-
sion from the results may be less positive than the authors
suggested, but this is nonetheless important. Obviously, pa-
tients with clinical signs and/or symptoms possibly related to
HF, particularly if alternative explanations are absent, should be
referred for further diagnostics. This is reflected by the high
specificity, resulting in an acceptable positive predictive value.
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However, this is clinically rather obvious and only of signifi-
cant value if the same test (in this case signs or symptoms) is
sufficiently sensitive with adequate negative predictive value to
safely exclude a relevant disorder (in this case cardiac dysfunc-
tion). This is apparently not the case! Thus from a primary care
perspective, the low sensitivity of this and other clinical signs
does not allow reliable screening because the large majority of
patients with cardiac dysfunction would still be missed.
The results of this study may be in some contrast with other
studies. Thus, Roalfe et al. investigated the diagnostic role of
clinical features and NT-proBNP. They identified four simple
clinical features (Male, history of myocardial Infarction, lung
Crepitations, and oEdema: so called MICE) that could accu-
rately triage between patients with suspected HF who should
be referred for echocardiography directly and those in whom
re fe r r a l shou ld depend on NT-p roBNP va lues
(sensitivity 90–96 %, specificity 58–63 %) [6]. However, the
population included in this analysis was at higher risk, which
may have contributed to the better performance of clinical
features for screening of HF.
In another large Dutch cross-sectional study, 721 primary
care patients with almost similar baseline characteristics (age
71±12 years, 65 % females, 52 % hypertension, 7 % CAD)
suspected of having HF (final prevalence 29 %) underwent a
standardised diagnostic work-up that included history, physi-
cal examination, ECG, X-ray, spirometry, laboratory testing,
and echocardiography. Hierarchical multivariable logistic re-
gression modelling revealed that the combination of three
items from history (age, CAD, and loop diuretics) plus six
from physical examination (pulse rate and irregularity,
displaced apical beat, murmur, rales, and increased jugular
venous pressure) predicted HF quite accurately (c-statistic
0.83). The addition of NT-proBNP to the diagnostic workup
added diagnostic power and increased the c-statistic to 0.86.
The diagnostic rule derived from this study showed to be very
robust when used in external validation studies (c-statistic
0.88–0.95) [7]. This indicates that information obtained from
the history and physical examination may be of importance if
HF is suspected in relatively high-risk populations, but they
may be considerably less valuable in patients at low risk for
HF. Unfortunately, Ringoir et al. fail to give the prevalence of
HF, but this is clearly much lower than the prevalence of
echocardiographic abnormalities.
Another important shortcoming is the fact that ECGs were
not part of the focus of their study. However, hypertensive
heart disease is often associated with electrocardiographic
(ECG) abnormalities and a 12-lead ECG is recommended in
all patients for screening of cardiac dysfunction in hyperten-
sion [3, 4]. Although there are clear limitations, an abnormal
ECG can detect echocardiographic left ventricular systolic
dysfunction in suspected HF patients (area under the summary
ROC curve 0.84, 95 % CI: 0.33–1). Conversely, a normal
ECG recording may exclude left ventricular systolic
dysfunction in most cases [8]. Therefore, the diagnostic value
of signs and/or symptoms of HF as a rather isolated screening
tool is clinically less relevant. Moreover, the authors do not
provide a model of the diagnostic accuracy by combining all
clinical parameters found to be significantly correlated with the
presence of cardiac dysfunction. Additionally, laboratory test
including NT-proBNP measurements could have significantly
increased diagnostic yield, but such information is lacking.
One important reason for the discrepancies between this
study and others may be related to differences in defining HF.
A uniform definition of HF is well published in the guidelines,
but in clinical reality and also in some of the studies men-
tioned, different definitions were used, making direct compar-
ison difficult. Moreover, the investigators of the current study
used different cut-off values to define systolic dysfunction
than proposed by international guidelines (ESC:
LVEF < 50 %) [3]. Similarly, diastolic dysfunction was not
defined according to current recommendations (LA volume
index > 34 mL/m2, E/a > 1 [pseudonormal or restrictive
pattern], DT < 150 ms, S/D < 1, e’ < 8 cm/s, E/e’ >15, etc.)
[9]. Even more importantly, the authors do not provide sepa-
rate analysis for patients with reduced and those with pre-
served ejection fraction. Although we agree with the authors
that investigating only systolic dysfunction is missing an
important group of patients with clinically relevant cardiac
dysfunction, the distinction is very relevant as treatment dif-
fers significantly between the two. In fact, one reason for
performing echocardiography may be the distinction between
preserved and reduced left ventricular systolic function.
Whereas the former is important for risk stratification and
more aggressive treatment of risk factors, the latter requires
additional specific treatment even if asymptomatic [3].
The results of this study do emphasise that diagnosing
cardiac dysfunction in primary care remains difficult and
cannot be reliably performed based on clinical signs and
symptoms alone. Previous studies suggest that the combina-
tion of clinical signs, patient characteristics and additional
testing such as ECG and NT-proBNP may be more accurate,
at least in screening patients with suspected HF in primary
care and triage patients for echocardiography. However, pro-
spective studies should validate this, as is currently done in the
REFER (REFer for EchocaRdiogram) study [10]. Moreover,
similar studies in lower risk patients as investigated byRingoir
et al. are urgently needed. Until such results become available,
we recommend following the guidelines for management of
arterial hypertension [4]: all patients with hypertension should
receive an ECG in addition to the clinical evaluation. Those
with any abnormal finding or high risk of having heart failure
should be referred for echocardiography.
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